Educational Objectives

Educational Objectives

Upon completion of this activity, participants will be able to:

• Provide an educational overview of cardiac dysfunction related to cancer treatment

• Discuss contemporary cancer therapies—such as immune checkpoint inhibitors and CAR-T cell therapy—and evaluate their interactions with cardiovascular disease

• Identify cardiac risk factors, apply management strategies, and develop monitoring plans

• Evaluate effective treatment approaches for patients at risk of long-term cardiotoxicity

• Create a prioritized list of key areas for understanding the mechanisms behind cardiovascular toxicities linked to cancer therapies

• Explore innovative approaches to advancing health outcomes in Cardio-Oncology

Accreditation & Credit Designation

In support of improving patient care, RUSH University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

RUSH University Medical Center designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

For Nurses

RUSH University Medical Center designates this live activity for a maximum of 5.00 nursing contact hour(s).

For Pharmacists

RUSH University Medical Center designates this knowledge-based activity for a maximum of 5.00 contact hour(s) for pharmacists.